Category: Emerging Infectious Diseases
CDC Warns About Enterovirus D68, the Virus Linked to Paralysis in Kids
Prevention – The Centers for Disease Control and Prevention (CDC) is warning about an increase of a respiratory illness that’s linked to paralysis in kids. It’s called enterovirus D68, and the CDC says it’s currently on the rise in the U.S. The CDC shared the news in its Morbidity and Mortality Weekly Report, which points out […]
Sep 29, 2022
CDC MMWR Enterovirus D68 (EV-D68) caused biennial outbreaks of severe respiratory illness and acute flaccid myelitis (AFM) in the United States in 2014, 2016, and 2018. After an extended period of low EV-D68 circulation during the COVID-19 pandemic, surveillance data suggest increased detection of rhinovirus/enterovirus and EV-D68, concurrent with increased emergency department visits by children […]
Sep 29, 2022
Zoonotic diseases like COVID-19 and monkeypox will become more common, experts say
NPR – Cases of monkeypox are on the rise in the U.S., with about 67,600 global cases, including about 25,500 in the U.S. Simultaneously, the world is still facing a COVID-19 pandemic, despite the number of cases tapering off. Researchers say these types of viruses, known as zoonotic diseases, or ones that spread between humans and animals, will […]
Sep 29, 2022
Monkeypox Spread Is Slowing in the US. Now, the Focus Is on Prevention
Bloomberg – US monkeypox cases are declining nationally, driven by a growing vaccine supply and community-based outreach, marking a hopeful sign for an outbreak that’s afflicted more than 25,000 Americans. Since the outbreak peaked in August, daily case rates have been dropping, data show, with just 66 new infections reported on Sept. 21. In cities where monkeypox cases exploded […]
Sep 29, 2022
JAMA – Question Is SARS-CoV-2 seropositivity associated with symptoms of myalgic encephalomyelitis and/or chronic fatigue syndrome (ME/CFS) in children and adolescents? Findings This cross-sectional study of hospital-based SARS-CoV-2 seroprevalence surveys in Germany compared seropositive and seronegative children and adolescents and identified an excess of possible ME/CFS symptoms with serological evidence of preceding SARS-CoV-2 infection. This association almost […]
Sep 28, 2022
Remdesivir resistance in transplant recipients with persistent COVID-19
Clinical Infectious Diseases – New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications. Download […]
Sep 28, 2022
SARS-CoV-2 mutation leads to resistance to remdesivir in 2 patients
CIDRAP – A report published yesterday in Clinical Infectious Diseases describes a new SARS-CoV-2 mutation that confers resistance to the COVID-19 antiviral drug remdesivir in two persistently infected kidney transplant recipients treated with immunosuppressive drugs. NYU researchers identified the V792I RNA-dependent 25 RNA polymerase mutation in the transplant patients, who were hospitalized and experienced life-threatening COVID-19 complications […]
Sep 28, 2022
CDC – Increases in severe respiratory illness and acute flaccid myelitis (AFM) among children and adolescents resulting from enterovirus D68 (EV-D68) infections occurred biennially in the United States during 2014, 2016, and 2018, primarily in late summer and fall. Although EV-D68 annual trends are not fully understood, EV-D68 levels were lower than expected in 2020, […]
Sep 28, 2022
Japan’s COVID herd immunity near 90% after Omicron wave, study says
Reuters – Japan’s population level immunity to COVID-19 has reached about 90% in major population areas after a recent Omicron wave, though that level of protection is likely to diminish in a matter of months, according to a study published on Tuesday.
Sep 28, 2022